TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancerHERBST, Roy S; PRAGER, Diane; RAMIES, David et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 5892-5899, issn 0732-183X, 8 p.Article

Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung CancerGIGI CHEN; HUYNH, Minh; FEHRENBACHER, Lou et al.Journal of clinical oncology. 2009, Vol 27, Num 9, pp 1401-1404, issn 0732-183X, 4 p.Article